Aiping Pharm

JUN 8, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Levetiracetam (Labeling)

U.S. Food and Drug Administration

This is an FDA supplemental approval for levetiracetam labeling; it documents a regulatory action, not a clinical trial, and does not report efficacy or safety data.